Altogether, immunisation with OVA and CpG delivered by ACM polymersome nanocarriers induced strong anti‐tumour effector CD8+ T cell responses, mediated tumour regression and improved the survival of tumour‐bearing mice. Here, CD8A is linked to neoplasm.